Overview

Withdraw Drug in Stable IgG4-Related Disease

Status:
Not yet recruiting
Trial end date:
2022-10-15
Target enrollment:
Participant gender:
Summary
Evaluation and prediction of relapse risk after glucocorticoid or immunosuppressant withdrawal in patients with stable IgG4 related disease: a prospective cohort study from china.
Phase:
N/A
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Chinese PLA General Hospital
Peking University People's Hospital
Shengjing Hospital
The People's Hospital of Hebei Province
Tongji Hospital
Treatments:
Glucocorticoids
Immunosuppressive Agents